11 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Call for Nominations: Rawls-Palmer Progress in Medicine Award
The Rawls-Palmer Progress in Medicine Award was established in 1978 by Dr. W. B. Rawls to further his commitment to continuing medical education and its impact on patient care. This award was founded through the generosity of the late Dr. and Mrs. W.B. Rawls, and honors the memory of their parents.
The goal of the Rawls-Palmer Progress in Medicine Award is to incorporate the efforts of modern research in patient care and to help bridge the gap between the results of research and its application in patient care.
Eligibility
The candidate must be an investigator who is actively involved in high-quality clinical pharmacologic research and capable of delivering an engaging, comprehensive lecture on recent developments in clinical pharmacology and therapeutics.
Prize and Presentation
The Rawls-Palmer Progress in Medicine Award is presented at the ASCPT Annual Meeting. The recipient will present a lecture focusing on recent developments in clinical pharmacology. In addition, the recipient will receive a $1,000 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
The nomination deadline is Thursday, June 27, 2013.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at meetings@ascpt.org.
Call for Nominations: William B. Abrams Award in Geriatric Clinical Pharmacology
The William B. Abrams Award in Geriatric Clinical Pharmacology was established with support from the Merck Company Foundation in 1996 to honor an investigator in geriatric clinical pharmacology for outstanding contributions to the field.
Dr. Abrams, a Past President of ASCPT, had a long and illustrious career in the pharmaceutical industry, mostly at the Merck Research Laboratories. Among his many accomplishments in geriatric clinical pharmacology, he was the founding Co-Editor of the Merck Manual of Geriatrics, created the Scientific Section on Geriatric Clinical Pharmacology of ASCPT, and developed and funded post-doctoral training programs in geriatric clinical pharmacology.
Dr. Abrams' objective in establishing this award was to encourage more young scientists to enter the field of geriatric clinical pharmacology by recognizing accomplishments in the field at the Society's Annual Meeting.
This award is funded on behalf of Dr. Abrams through the generosity of The Merck Company Foundation.
A nominee must be an investigator in geriatrics who is actively involved in high-quality teaching and research in geriatric clinical pharmacology. Prize and Presentation
The William B. Abrams Award in Geriatric Clinical Pharmacology is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Henry W. Elliott Distinguished Service Award
The Henry W. Elliott Distinguished Service Award was established in 1979 to recognize an ASCPT member who has gone above and beyond the call of duty in service to the organization.
The goal of the Henry W. Elliott Distinguished Service Award is to acknowledge outstanding efforts on behalf of the organization by an individual member and in doing so, encourage other ASCPT members to contribute their time and talent to the Society.
A nominee must be a member of ASCPT and cannot have held the position of President-Elect or President of the Society within the last five years. The essential criterion documented evidence of excellent service to the organization. One or two outstanding acts of service or a long record of many acts of service may justify the award. The recipient should have a record of continuous service to the Society, including one or many major accomplishments.
The Henry W. Elliott Distinguished Service Award is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Sheiner-Beal Pharmacometrics Award
The Sheiner-Beal Pharmacometrics Award has been established as an ASCPT Award by the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) to acknowledge the pioneering contributions of Drs. Lewis B. Sheiner and Stuart Beal to the scientific discipline of pharmacometrics.
Definition
Pharmacometrics is defined as the science that quantifies drug, disease and clinical trial information to aid efficient drug development, regulatory decisions and rational therapeutic decision making in patients. It uses models that are generally based on pharmacology, physiology, genetic constitution and/or disease for quantitative analysis of interactions between drugs and patients. The domain of pharmacometrics includes the application of techniques that address the interactions between pharmacokinetics, pharmacodynamics, pharmacogenomics, and disease progression with a focus on populations and variability in the exposure-response relationship.
Goal
The goal of the Sheiner-Beal Pharmacometrics Award is to recognize outstanding achievements at the forefront of research or leadership in pharmacometrics and/or application of pharmacometric concepts and techniques to enhance research, development, regulatory evaluation, and/or utilization of therapeutic products.
The candidate must be an investigator or leader who is actively advancing the scientific discipline of pharmacometrics and/or its impact on research, development, regulatory evaluation, or utilization of therapeutic products, and is capable of delivering an engaging and comprehensive lecture on pharmacometrics. The award is intended to recognize clinical pharmacologists, clinician scientists, computational scientists, statisticians and others in academia, industry, government agencies, or consulting whose work falls within the scope of the definition of pharmacometrics.
The Sheiner-Beal Pharmacometrics Award will be presented annually at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient will receive a $1,500 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Leon I. Goldberg Young Investigator Award
The Leon I. Goldberg Young Investigator Award was established in 1986 to honor a young scientist for accomplishments in the field of clinical pharmacology achieved early in his/her career.
The goal of the Leon I. Goldberg Young Investigator Award is to encourage and recognize young scientists active in the field of clinical pharmacology.
There are no restrictions concerning the scientific field in which nominees have earned their doctoral degrees. Nominees must be no more than 45 years of age as of March 1 of the year in which the award is presented. Although it is encouraged, a nominee need not be a member of the Society.
The Leon I. Goldberg Young Investigator Award is presented at the ASCPT Annual Meeting. The recipient will deliver a lecture on his/her work. In addition, the recipient of the award will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration are reimbursed by the Society.
Call for Nominations: Gary Neil Prize for Innovation in Drug Development
The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several other biotech companies.
The goal of the Gary Neil Prize for Innovation in Drug Development is to stimulate the application of innovative science to clinical drug development by recognizing outstanding individuals or teams who have been leaders in this area.
Individuals as well as teams who have demonstrated leadership in the application of significant, innovative science to clinical drug development. The award is open to individuals from all clinical pharmacology employment sectors.
The Gary Neil Prize for Innovation in Drug Development will be presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $2,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at meetings@ascpt.org
Call for Nominations: Oscar B. Hunter Memorial Award in Therapeutics
The Oscar B. Hunter Memorial Award in Therapeutics was established in 1955 to honor individual scientists for outstanding contributions to clinical pharmacology and therapeutics. This award recognizes a meritorious career in drug research, excellence or contributions in direct patient care, and a distinguished teaching career.
The Oscar B. Hunter Memorial Award in Therapeutics is the Society's premier award. The goal of the award is to honor a scientist for outstanding contributions to clinical pharmacology and therapeutics over the individual's professional life.
A nominee must be able to provide evidence of an exemplary career in drug research, significant contributions to excellence in patient care, and a distinguished teaching career.
The Oscar B. Hunter Memorial Award in Therapeutics is presented at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient of the award will receive a bronze medal mounted on a plaque and a $1,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Cancer Projects: Repurposing of Drugs - Breakthrough in Cancer Treatment
Funding Cancer Projects
Reliable Cancer Therapies (RCT) announces € 300 000 for projects repurposing existing drugs for cancer treatment. The drugs must have been developed and approved for other indication(s). Relevant clinical trial endpoints (cancer survival & tumor response) should be the primary research assessments.
RCT also promotes collaborative research projects between researchers at different universities and/or organisations.
About the Call for Applications
• Medical Degree required for Principal Investigator (PI) or co-PI
• 1 application per PI
• Resubmission is allowed (please indicate the reason for previous decline)
• Set up of proposal:
◦ Application form: maximum 2 pages
◦ in appendix 1: biography & references of the PI and co-PI
◦ in appendix 2: overview of the budget (including salaries, supplies, equipment, patient care costs, and other expenses).
• If your cancer project is selected in the first round, detailled information will be requested for consideration of the final award selections.
• Approved proposals will be supported with a maximum of € 300 000 for 3 years.
Reliable Cancer Therapies (RCT) is a non-profit organization based in Switzerland that provides research-based information on cancer therapies and selectively funds the development of promising therapies.
RCT investigates information on cancer therapies for evidence to then inform the public about evidence-based cancer treatment choices. We help cancer patients and caregivers to structure and absorb the complex nature of cancer information for their decision-making on registered complementary or alternative therapies.
RCT is continuously looking for cancer therapies that have never been thoroughly examined and consider financing cancer treatments that can be deemed promising based on measurable results.
Application Deadline
Application deadline is June 28, 2013 at 8am GMT. Incomplete or late applications will not be considered.
Please submit applications to Ann-Christine Moenaert (info@reliablecancertherapies.com)
RCT will review the applications internally with the support from our appropriate external experts by August 14, 2013. If the project is selected in the first round, more detailled information will be requested by September 13, 2013. Final decisions will be made on October 4, 2013.
Contacts at RCT
Please direct any technical questions to Ann-Christine Moenaert (info@reliablecancertherapies.com)
Please contact Gauthier Bouche, MD (info@reliablecancertherapies.com) for any clinical or scientific questions.
American College of Cardiology Foundation Young Investigator Awards Competition
The Young Investigator Awards competition encourages and recognizes young scientific investigators of promise, upon whom progress in the field of cardiology is dependent. A manuscript and abstract summarizing any problem that relates to cardiovascular disease whether it be in etiology, pathophysiology, diagnosis, or therapy.
Award Categories include the following:
1. ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology
2. Physiology, Pharmacology and Pathology
3. Clinical Investigations, Congenital Heart Disease and Cardiac Surgery
4.Cardiovascular Health Outcomes and Population Genetics
*Doctorate level nurses, physician assistants and clinical pharmacists in research are strongly encouraged to apply in this category
Eligibility: Physicians, scientists, medical students, and other healthcare providers currently in residency or fellowship programs, or are no more than three years out of training. PhD, PharmD or DNP candidates who are no more than three years out of training may also apply.
Note: Candidates will be eligible for this award up to four years after completion of training if more than three months of family or sick leave was taken during training or in the first three years after completion of training.
The Award: The first place winner for each category receives $2,000, second place winners receive $1,000; three honorable mentions in each category receive $500. Travel, hotel and meals up to $1,500 will be reimbursed for all 20 finalists to attend the YIA Competition at ACC.14 in Washington, DC.
Funding Source: Support for the ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology is provided by a grant from CV Path Institute and the family of Herman K. Gold.
Deadline: October 11, 2013
For more information: Email Kristin Robertson or call 800-253-4636, ext. 6390.
American Society of Pharmacognosy Varro E. Tyler Prize
The Varro E. Tyler Prize is to recognize an individual who has made outstanding scientific contributions to the broad field of dietary supplements, with special emphasis on botanicals. The contributions should be in an area of phytochemistry, pharmacognosy, or pharmacology. Notable contributions to botanical studies outside these primary areas of emphasis, including, for example, clinical investigations, may also be eligible for consideration.
The Varro E. Tyler Prize will consist of a suitably inscribed plaque, a monetary prize of $5000, and travel expenses to the meeting where the award will be made. Selection: To be made by a committee appointed by the President of the American Society of Pharmacognosy (ASP), consisting of a chair and at least two other members. Eligibility and Mechanism: The Varro E. Tyler Prize will be awarded either at the annual or an interim meeting of the ASP. Recipients must be present in person to receive it. Applications/nominations (one electronic copy) for the Varro E. Tyler Prize must be received by the chairman of the Prize Committee at least two months prior to the meeting at which the award is scheduled. No special form is required, but the application should include a letter outlining the candidate’s significant contributions to the field and a detailed curriculum vitae of the nominee, including a complete listing of publications. Reprints of 2-3 significant papers may be included. Other types of supporting documents that may be listed are books, unpublished speeches, patents, and the like. Up to two supporting letters may also be submitted on behalf of a candidate/nominee. Membership in the ASP is not a requirement for consideration, nor is eligibility restricted on the basis of nationality.
To nominate: One electronic copy of a completed nominations should be sent to the committee chair.
Submissions must reach the chair no later than September 15. Applications will not be returned. On request, the Committee will hold unsuccessful submissions for reconsideration in future years.
Note that the Varro E. Tyler Prize is administered separately.
12next
